Home Investors Important Notice This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including the ones under development on this web site. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider. I Agree Investor Relations Stock Quotes (TSE 1st:4503) View Stock Performance IR News Oct 29, 2021 Posted Financial Results for 2Q/FY2021 Jul 30, 2021 Posted Financial Results for 1Q/FY2021 May 27, 2021 Posted Notice of Convocation of the 16th Term Annual Shareholders Meeting May 26, 2021 Updated “Strategic Plan” Section Apr 27, 2021 Posted Financial Results for FY2020 Jan 29, 2021 Posted Financial Results for 3Q/FY2020 View All >> Corporate Strategic Plan 2021 Our Corporate Strategic Plan 2021 provides a path to realizing VISION in the coming years. Read More Financial Information Review our consolidated business results, forecasts and financial data, etc. Read More Annual Report Integrated report that includes financial and non-financial (ESG) information. Introducing Astellas' efforts for creating value for sustainable growth. Read More IR Library This section contains IR related information for shareholders and investors. Various IR materials can be downloaded from here. Read More IR Calendar Find our upcoming IR events. Read More Stock & Rating Information Year-end dividend - March 31 Interim dividend - September 30 Note: In accordance with the Company's Articles of Incorporation, if cash dividends are not claimed for three (3) full years from the day of commencement of payment, the Company shall be relieved of the obligation to make such payment. Read More Analyst Coverage List of analysts of securities companies and research companies who make recommendations and reports of Astellas' performance, etc Read More Cautionary Statement The information disclosed in this part of the Astellas Website is provided for better understanding of Astellas by stakeholders including shareholders and investors, but is intended to neither solicit nor recommend the purchase of the Astellas's stock. Read More VISION We introduce our VISION and common definition of VALUE, the foundation to realize our VISION. Corporate Strategic Plan 2021 You can see the materials related to CSP 2021 here. Major Pipeline We introduce the progress of our clinical development projects called “R&D pipeline”. We update R&D pipeline 4 times annually in our quarterly performance reports. Bottom footer menu SITE MAP PRIVACY POLICY ACCESSIBILITY TERMS OF USE CONTACT US DISASTER INFORMATION FOR EMPLOYEES © Astellas Pharma Inc.